Lantern Pharma Inc.

NASDAQ: LTRN · Real-Time Price · USD
4.61
0.04 (0.88%)
At close: Aug 15, 2025, 3:59 PM
4.66
1.08%
After-hours: Aug 15, 2025, 04:32 PM EDT

Lantern Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
7.51M 21.94M 37.2M 51.52M
Short-Term Investments
16.5M 19.36M 17.99M 19.2M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
36.74K 25.87K 17.89K 1.02M
Receivables
97K 860K 592K 181K
Inventory
n/a n/a n/a -181K
Other Current Assets
1.14M 745.65K -50.82K n/a
Total Current Assets
25.25M 43.34M 58.72M 72.72M
Property-Plant & Equipment
287.43K 280.42K 95.69K 216.19K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
324.16K 306.29K 113.58K 1.23M
Total Assets
25.57M 43.65M 58.84M 73.95M
Account Payables
4.14M 942.21K 932.41K 681.11K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
190.81K 172.97K 52.89K 152.06K
Other Current Liabilities
4.33B 1.39M 1.76M 1.34M
Total Current Liabilities
4.33B 2.68M 2.8M 2.33M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
52.79M n/a n/a n/a
Total Long-Term Liabilities
52.84M 61.5K n/a 52.89K
Total Liabilities
4.38M 2.74M 2.8M 2.38M
Total Debt
243.66K 234.47K 52.89K 204.95K
Common Stock
1.08K 1.07K 1.09K 1.11K
Retained Earnings
-76.03B -55.24M -39.28M -25.02M
Comprehensive Income
153.99K -107.46K -371.39K -92.69K
Shareholders Equity
21.19B 40.91M 56.04M 71.57M
Total Investments
16.5M 19.36M 17.99M 19.2M